Shreya Patel, MD
MOHS-Micrographic Surgery · West Orange, NJNPI 1497214233
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,353 of the $2,881 with a category attached, or 81.7%. 19 manufacturers reported payments, led by AbbVie at 29.8% of the total. Reporting peaked in 2023 at $1,318 and has fallen 90.4% since, to $127 in 2025.
Across 72 payments — averaging $40.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$858
- Lilly USA, LLC$486
- Johnson & Johnson$359
- Janssen Scientific Affairs, LLC$256
- UCB, Inc.$213
- Amgen$135
- plus $574 from 13 others
What the payments were for
- Travel & lodging$32811%
- Food & beverage$2,35382%
- Education$2007%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $858 |
| Lilly USA, LLC | 9 | $486 |
| Johnson & Johnson | 5 | $359 |
| Janssen Scientific Affairs, LLC | 2 | $256 |
| UCB, Inc. | 10 | $213 |
| Amgen | 9 | $135 |
| Dermavant Sciences, Inc. | 1 | $125 |
| Pfizer | 1 | $87 |
| Regeneron Healthcare Solutions, Inc. | 5 | $81 |
| Novartis | 2 | $58 |
| Incyte Corporation | 2 | $41 |
| Sanofi | 2 | $34 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Arcutis Biotherapeutics, Inc. | 2 | $28 |
| Organogenesis Inc. | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| LEO Pharma Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,881 in reported general payments places this provider in the 70th percentile of 30 mohs-micrographic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $39,571 |
| Gentamicin Sulfate | 150 | $4,988 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 43 | $2,598 |
| Doxycycline Monohydrate | 145 | $1,684 |
| Ketoconazole | 82 | $1,184 |
| Triamcinolone Acetonide | 81 | $824 |
| Clindamycin Phosphate | 20 | $697 |
| Mupirocin | 49 | $366 |
| Doxycycline Hyclate | 17 | $288 |
| Hydrocortisone | 33 | $144 |
| Cephalexin | 17 | $79 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in West Orange
- Marc GlashoferWest Orange$175K
- David GoldbergHackensack$820K
- Kehua LiSewell$22K
- Steven WangBasking Ridge$11K
- John VinePrinceton$8K
- Lian Jie LiPhillipsburg$7K
- David NajarianRandolph$5K
- Parth PatelBridgewater$4K
- Jeffrey WhitworthWoodland Park$3K
- Otter AspenRockaway$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.